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ABSTRA K 
EPIDEMI MALARIA PADA TRANSMIGRAN DI IRIAN JA YA 
Malaria merupakan masalah kesehatan yang penting untuk masyarakat transmigrasi di daerah 
endemisitas malaria tinggi seperti Irian Jaya. Di Arso, -epidemi malaria timbul setelah dua sampai 
enam bulan sesudah tibanya transmigran baru. Dalam tiga bulan angka parasitemia bisa mencapai 
70% dan hampir 10% dari transmigran mendapat malaria berat yang membutuhkan rujukan ke rumah 
sakit dalam enam bulan pr rtama. 
Usaha penanggulangan malaria di daerah seperti Arso menghadapi berbagai tantangan dan 
hambatan karena tingginya derajat resistensi parasit terhadap klorokuin, fasilitas dan kemampuan 
untuk diagnostik yang terbatas, sulitnya pengendalian vektor (An. punctult?tus group) dan tidak 
adanya strategi untuk menghilangkan sumber infeksi yang asimptomatik. 
Berbagai usaha yang dapat mengurangi risiko epidemi malaria di daerah transmigrasi Irian 
Jaya ialah antara lain pemberian projilaksis selama tiga bulan (selain klorokuin perlu 
dipertimbangkan pemberian primakuin bag; transmigran yang tidak hamil dun tidak menderita 
def~siensi G-6-PD), peningkatan fasilitas diagnostik dan pengobatan/termasuk rujukan untuk kasus 
malaria berat), pemakaian kelarnbu, penemuan kasus aktif untuk menghilangkan gametocytemia yang 
asimptomatik (selama enam bulan) serta penyuluhan dan partisipasi masyarakat dalam 
pemberantasan malaria (termasuk pemhinaan kader kesehatan). 
Untuk melaksanakan kegiatan tersebut di atas perlu disediakan tenaga dan sumber dana yang 
khusus. 
lNTRODUCTION lack the infrastructure and econon~ic resources 
to defend themselves against malaria, and the 
Endemic malaria impedes socioeconor~~ic disease rcsrricts the development of those 
development wherever it  occurs. Malaria resources. Perhaps the most effective approach 
contributes to a cycle of infection, disease and to breaking this cycle is economic inlervention. 
poverty. Commurlities affected by maiar~a often 1.e , development of a social and economic base 
* W.S. Naval Medical Research Unit No. 2 Jakiir'La Yncionesla 
** C;lormr.urlicable Disca~cs R..est:arcl; C~:ltic; ?T2.1!-:',", Jsb;rrta, I:tbor:es~ : 
Epidemic malaria among transmigrants .............. J.K. Baird et al 
to support a broad spectrum of malaria presents a wide array of malarious 
control activities. Such measures would environments; no single plan could be 
include not only strategies that directly universally effective. Control measures are best 
attack the parasite and vector, but also those tailored to the local habitat, both in a biological 
which empower citizens to fight against the and socioeconomic sense. Nonetheless, the 
disease and increase motivation, education and technical detail required for development of 
organizational skills. site- or region-specific malaria control is within 
Broad institution of these elements may be 
impractical because reaching and maintaining 
a presence in remote malarious areas is often 
difficult. On the other hand, linlung 
community-based control strategies to targeted 
economic development offers an 
opportunity to overcome that difficulty. When 
planners of such activities include the 
development of rational malaria control 
activities, and set aside the resources to achieve 
specific goals, then abatement of endemic 
malaria may ensue. This may be especially 
important since abrupt economic development 
activities often begin with social and 
environmental changes that may destabilize and 
exacerbate malaria. 
Transmigration in Indonesia represents a 
positive economic intervention which may serve 
as a platform for a broad spectrum of malaria 
control activities. This programmatic spurring 
of social and economic development creates 
ideal circumstances for instituting rational 
plans for the control of endemic malaria. The 
huge investment of financial and manpower 
resources for transmigration dwarfs the 
resources and effort required to simultaneously 
install measures to minimize morbidity and 
mortality due to malaria. Moreover, the 
motivation to do so should be compelling from 
the practical prospective of protecting the large 
investment of people and resources that any 
transmigration project represents. 
An impoX"tant difficulty with committing to 
malaria control at the outset of a bsmsmigation 
project is confidence in the plan. Indonesia 
our reach. In many instances, an awareness of 
the published scientific literature may be 
sufficient to develop a rational plan. Reliable 
information about malaria provides confidence 
in the plans to control it. 
The term 'reliable' should not be confused 
with 'sophisticated'. High biotechnology and 
the thrilling advancements at its cutting edge 
are not essential for protecting transmigrants 
and indigenous people from malaria. A 
disciplined application of 'low-tech' research 
alone may provide enormous dividends in 
public health. Limited ability to participate in 
high biotechnology work should not 
compromise confidence in ability to develop 
effective and practical measures of malaria 
control. 
In this article we shall examine the 
problem of epidemic malaria among new 
transmigrants in the Arso region of Irian Jaya, 
and then consider the results of collaborative 
studies between the Communicable Diseases 
Research Centre of the National Institute of 
Health Research and Development 
(LITBANGKES), the Irian Jaya Provincial 
Health Service, and the U.S. Naval Medical 
Research Unit No. 2 (NAMRU-2). These shall 
be analyzed as though developing a rational 
approach to avoiding the problems of epidemic 
malaria in new transmigrant communities in 
northeastern Irian Jaya. The reader may benefit 
by recogmzing the 'low-tech' nature of the 
observations gathered in Irian Jaya. No 
deficiency in technical capability should 
prohibit sirmila- smdies in other areas of 
Irad~nesia by other investigators. 
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EPIDEMICS IV. Figure 3 shows the prevalence of symptoms 
of malaria consistent with uncomplicated 
An outbreak of malaria justifiably creates malaria (without slide confjmation) in Ar& 
alarm and an atmosphere of crisis. Outbreaks PIR IV, and ~i~~~~ 4 shows the incidence 
occur typically in with the density of severe malaria. These observations 
movement of nonimmune Popie into hyper- to demonstrate the devastating impact of endemic 
holoendemic malarious areas, such as malaria on a community of newly exposed 
transmigration to the Arso region of people. For example, 91 cases of severe malaria 
northeastern Irian Jaya. In Arso, epidemics 
occurred among the one thousand residents of 
usually occur within two to five months of 
arrival. This incubation period represents the Aaso PIR IV during their first 6 months, ie., 
of forces which create the of the ~ o ~ u l a t ~ o ~ ;  among these, 
epidemic; infection, transmission and 
reinfection. A cascade of disease occurs as 
more and more individuals contribute to the 
pool of infectious gametocytes. In 
transmigration villages where epidemics occur, 
one must examine the measures taken to 
prevent disease and rationally consider the 
reasons for inadequate malaria control. 
First, we shall examine data that illustrate 
the onset of epidemic malaria. In Arso PIR I1 
in 1988 surveys of blood films were conducted 
during the first months of residence. Figure 1 
illustrates those results. Infection pressure was 
apparently intense upon arrival; 14% were 
infected after just 10 days (the biological 
incubation period is 8 to 14 days). Withn just 
three months over 70% were parasitemic. 
Another study of epidemic malaria among new 
transmigrants focused on Arso PIR IV in 1992 
several deaths were reported. 
The data of Figures 1 to 4 raise two 
important questions: 1) How could such 
spiking of infection and disease occur in the 
face of chemoprophylaxis, chemotherapy, and 
vector control activities? and 2) What could 
prevent such an epidemic? Addressing these 
questions largely accounts for the remainder of 
this text. The discussion also illustrates the 
utility of basic information gathered from 
field-based studies in grasping the force of key 
determinants of malaria in isolated areas. 
Understanding these features assists the 
formulation of control strategies. 
DETERMINANTS OF EPIDEMIC 
MALARIA IN A NEW COMMUNITY 
Force of infection. 
(Figure 2). Here the onset of the epidemic was 
slower. The difference between these two In the Arso region of Irian Jaya, the incidence of malaria has been measured to be 
villages may be related to the populations of between 2 and 5 infections per person year.'.2 In infected local Irianese people: large numbers in 
ahe r  words, the average man, woman and child 
Arso PIR I1 and relatively few in Arso PIR IV. may be expected to experience to infections 
The extant pool infectious gametocyte by malaria parasites during the course of a 
carriers in PIR 11 caused an immediate single year, ~~~t residents of new 
epidemic, whereas several months were transmigration villages in Arso will develop 
required before the new arrivals themselves malaria within just a few weeks or months, as 
established their own pool of infectivity in PIR seen in Figures 1 and 2. 
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Other villages in the Arso region have had 
lower attack rates of malaria. For example, in 
Arso X and Arso M during 1992 and 1993, 
these new villages had <1 infection per person 
year (C. Ohrt and D. Fryauff, unpublished). 
This may be the result of the research-related 
clinics which operated continuously in those 
villages for over two years. Those clinics 
offered routine microscopic diagnosis and 
prompt therapy of malaria 24 hours a day, seven 
days a week in support of the routine services 
offered by the resident nurse. Prompt, accurate 
diagnosis followed by proper therapy and 
compliance -- these measures alone appear to 
greatly curtail infection pressure in 
transmigration villages, and appear to be key 
components of malaria control. 
Malaria transmission requires mosquitoes. 
The force of infection created by mosquitoes in 
Arso has been measured (M.J. Bangs and B.A. 
Annis, unpublished, as described by J.K. Baird 
in reference 2). Each night, approximately 15 
potential vectors feed upon an unprotected 
person. With an average sporozoite rate (the 
percent of anophelines carrying sporozoites) of 
about 1%, this means that the average exposure 
of a person in Arso will be one infective bite 
about once each week. Fortunately, the natural 
efficiency of inoculation, ie., the percent of 
these potentially infectious bites that result in 
patent malaria, may be just lo%.' 
Naturally acquired immunity and inborn 
resistance. 
Debilitating episodes of spiking fevers, 
chills and malaise typically occur in people 
without prior exposure ro malaria infection, 
with a significant risk of d,ath in1 , jive persons 
infected with Plasmodium Jlrlciparum. Figures 
1 to 4 demonstrate the susceptibility of 
nonimmune people to endemic malaria. In 
contrast, adults with lifelong exposure to heavy 
infection pressure only occasionally show 
symptoms of malaria, even when parasitemic. 
Naturally acquired immunity to malaria is the 
basis of this difference and has been the subject 
of many research studies in Irian J a ~ a . ~ - ~  
Natural immunity fails to develop where 
malaria is epidemic, hypoendemic or 
mesoendemic. For example, there is 
insufficient transmission of malaria on Java or 
Bali for residents to develop naturally acquired 
protection. The risk of acquiring malaria on 
Java is diminishingly small outside of the few 
foci of chronic endemicity; as low as 2 cases per 
100,000 person years.g Inborn abnormalities 
such as G-6-PD deficiency or sickle cell anemia 
may protect against malaria but these occur only 
rarely among Javanese." Javanese or Balinese 
transmigrants may be considered nonimmune to 
malaria when they first arrive at their new 
village. They are as susceptible to fulminant 
and life-threatening episodes of malaria as 
visitors from Jakarta or other non-malarious 
areas of the world such as Europe or North 
America. 
COUNTERMEASURES AGAINST EPIDE- 
MIC MALARIA 
Prophylaxis. 
Transmigrants coming to Irian Jaya 
receive weekly prophylaxis with chloroquine. 
As a general rule, most comply. Chloroquine 
prophylaxis was administered in Arso PIR IV in 
1992," yet an epidemic of malaria occurred in 
this community. Does chloroquine offer 
protection? 
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Our data suggest that in the Arso region, 
chloroquine offers only limited protection 
against malaria infection. Figures 5 and 6 
support this finding. On the other hand, 
chloroquine may offer some protection against 
clinical illness. Health care practitioners report 
reasonable success in resolving malaria 
symptoms when treating patients with 
chloroquine in the Arso region, even if the 
infection itself is not cured. However, clinicd 
protection may not occur in new transmigrants 
on chloroquine prophylaxis, as the doses used 
for prophylaxis are less than those used for 
treatment. In a year iang study of malaria 
prophylaxis in Arso XI, there were no 
significant differences in either the incidence of 
malaria parasitemia (Figure 6) or in the 
frequency of symptoms associated with 
parasitemia when study participants on 
chloroquine prophylaxis were compared to 
study participants on placebo (D. Fryauff, 
unpublished). 
Practical options to chloroquine for 
prophylaxis of transmigrants are few. A 
prophylactic agent for use in this environment 
should be safe and well tolerated, effective, 
affordable, and readily available. There are no 
known agents that satisfjl all these criteria. For 
example, chloroquine satisfies all of these 
criteria except one; it is not very effective. 
Conversely, a highly effective agent of 
prophylaxis that is prohibitively expensive or 
too toxic for general use is also not helpful. 
Compromise is nccessary and should be 
carefully weighed in light of sound evaluations 
of new agents. 
An addltlonal conslderatlon IS that at rs to 
t!rc henefit of  new t'ansmngrnnls, \dlc w~lil be 
resldtr~ 9snp Irma. ~ v a  a a*ka!arvxrs area, tc 
develop naturally acquired immunity (NAI) to 
malaria. Less effective antimalarials may assist 
the development of NAI. For example, when 
used as treatment, chloroquine provides relief to 
most patients by limiting clinical illness; 
however, it also results in persistent or 
recrudescent parasitemia in 70 to 90% of cases. 
T h s  strong stimulus to the immune system may 
accelerate the development of NAI. In contrast, 
highly effective antimalarial drugs restrict or 
prevent exposure to blood stage parasites, and 
may just postpone, rather than prevent, 
epidemics of malaria in new transmigrants. 
Data are needed to address this issue. 
One possible altzrnative to chloroquine is 
primaquine. During I992 to 1994 two research 
trials evaluated primaquine for chemopro- 
phylaxis against malaria in nonimmune Arso 
transmigrants. Both trials included a group 
receiving chloroquine. Figures 5 and 6 show 
that primaquine was effective prophylaxis 
against falciparum and vivax malarias among 
transmigrants in Arso. These two studies 
suggested that daily primaquine doses were well 
tolerated and did not cause significant 
toxicityi2~". 
Primaquine has not been safety tested for 
use during pregnancy and can cause hemolysis 
in some people with genetic deficiency in 
erythrocytic glucose-6-phosphate dehydrogenase 
(G6PD) activity. Thus primaquine is safest 
when pregnancy and G6PD testing are carried 
out before administration. A commercial kit for 
G6PD testing costs roughly US$0.65 per test at 
retail. (NADPH "Spot Test" for G6PD 
deficiency, Sigma Chemical Co.. St. Louis, 
Missouri, USA). For these reasons, pregnant 
women and any ialdividuals with G6PD 
deficiency were excluded from the two tnais 
dcscribd abovc. 
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Cumulative Incidence of Malaria 
Daily Primaquine Trial. Arso XI, Irian Jaya 
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Taking these considerations into account, 
primaquine prophylaxis may be a suitable 
alternative to chloroquine for protecting 
non-pregnant, G6PD-normal transmigrants 
from the onslaught of epidemic malaria. It 
carries the theoretical problem of preventing 
any exposure to blood stage parasites as it acts 
to kill liver stages before their release into the 
blood stream; thus persons on primaquine 
would have reduced opportunity to develop NAI 
to the blood stage parasites that cause clinical 
disease. 
Two additional drugs have been shown to 
be highly effective prophylactic agents in the 
Arso region. In a recent trial, both weekly 
mefloquine and daily doxycycline provided 
nearly 100% protection against malaria 
parasiternia (C. Ohrt, unpublished). Doxycyline 
is available in Indonesia, although it is more 
expensive than chloroquine, particularly as it 
must be taken on a daily basis. Mefloquine is 
expensive and not available in Indonesia, but is 
easy to take and reasonably safe and well 
tolerated. Neither of these agents can be given 
to pregnant women (although there is now some 
experience with using mefloquine in 
pregnancy). Meflquine is not recommended 
for infants, and doxycycline is not 
recommended for children less than eight years 
of age because it may cause abnormalities of 
bone and tooth development in younger 
children. 
Case Detection. 
Nurses residing in transmigration villages 
shoulder the responsibility for primary 
diagnosis and treatment of malaria. They 
generally have no on-site capability for 
microscopic diagnosis of malaria. Instead, they 
rely upon clinical presentation of patients with 
symptoms of malaria. This may largely explain 
the runaway course of malaria epidemics in new 
transmigration villages. Reliance upon clinical 
presentation for diagnosis of malaria, especially 
in villages under mass chloroquine prophylaxis, 
may accurately diagnose many of the 
symptomatic malaria infections. However, 
reliance on clinical criteria leaves undetected a 
pool of asymptomatic carriers, who contribute 
significantly in creating a rapidly burgeoning 
cycle of infection and reinfection, ie., an 
epidemic. Actively seeking asymptomatic 
infections and instituting effective therapy 
breaks this cycle. Of course, this requires a 
practical means of diagnosis. 
Several methods for diagnosis of malaria 
are now available. The Becton-Dickinson 
Company sells two kits; the QBC" fluorescent 
capillary tube system and ParaSight" Test 
dipstick system. These systems, in particular 
the dipstick test, offer the advantage of 
requiring relatively little expertise. It is not 
difficult to imagine the dividends in public 
health by having resident nurses routinely 
making reliable diagnoses of malaria with ease. 
However, this is not now economically 
practical. Each of these new tests costs about 
US$ I. A kabupaten making 100,000 diagnoses 
of malaria each year must allocate US$100,000. 
Bearing this cost must be weighed against that 
of training and equipping nurses to make a 
conventional diagnosis of malaria using Giemsa 
staining and microscopic examination. In our 
view, the conventional diagnosis may be a 
superior alternative in an endemic setting 
because the expenditure creates a pool of 
diagnostic expertise whereas the two new 
systems do not establish such residual benefits. 
Researchers have evaluated the QBC" and 
ParaSight" systems in Irian Jaya.I4-l6 In general, 
these systems are not sensitive below about 100 
parasites per microliter of blood. Low 
parasitemias are often characteristic of both 
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highly sensitive non-immune Javanese and 
Balinese transmigrants experiencing the first 
symptoms of malaria illness and the relatively 
immune Irianese residents of Arso 
communities. In addition, the ParaSightm test 
only detects P. falciparum, and thus provides 
falsely negative results in all patients with P. 
vivax infection. Development of a similar 
dipstick test for P. vivax is underway. 
Therapy. 
Resistance to chloroquine raises many 
difficult issues. Patients often remain 
parasitemic following treatment and, because 
gametocytes are either generated by suniving 
asexual blood forms or persist after therapy, 
they ultimately infect others. The poor efficacy 
of chloroquine in curing bloodstage infections 
in Arso is illustrated in Table 1. One may argue 
that chloroquine serves to protect people against 
severe malaria. However, chloroquine thus 
applied creates a pool of asymptomatic carriers 
of viable gametocytes, as chloroquine has no 
effect upon gametocytes. This places the 
community at risk of infection and invites a 
worsening resistance situation. Alternative or 
supplemental therapies may better manage the 
epidemic phase of malaria in new communities. 
Collaborative Li tbangkes-NAMRU-2 
research activities in Irian Jaya have been 
designed to address this problem. A strategy for 
therapy of malaria in Irian Jaya should include 
measures to kill incubating or dormant liver 
stage parasites and for neutralizing gametocytes 
in addition to the asexual blood stages usually 
targeted by treatment. Primaquine is the only 
currently available antimalarial that acheves 
both effective cure of liver stages and 
sterilization of circulating gametocytes. Thus, 
adjunctive primaquine therapy should be 
considered for non-pregnant G6PD-normal 
patients with malaria. Another benefit of 
primaquine, against P. vivax only, would be 
more effective chloroquine therapy. Studies in 
Arso revealed that adjunctive primaquine 
therapy rendered chloroquine-resistant vivax 
malaria" blood stage infection susceptible to 
standard chloroquine therapy (Table 2).18 
Table 1. Seven day in vivo tests of resistance to chloroquine by Plasmodium falciparum 
in the Arso region of Irian Jaya, 1987-1994. 
* Standard WHO case definitions applied. Data adapted from Baird et a]." and unpublished sources. 
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Table 2. Adjunctive primaquine therapy against faleiparum and vivax malaria in 
the Arso region of Irian Jaya, 1992-1994. 
* Standard chloroquine therapy of 25 mg/kg in three doses at 24 hr intervals. 
A One of three distinct regimens used: 
1) 25mg/kg chloroquine plus 0.5 mg/kg primaquine given daily for 14 days and on alternative 
days up to day 28. 
2) a single dose of 10 m a g  chloroquine plus primaquine as in regimen #I.  
3) chloroquine as in regimen #I plus 1.0 mg/kg primaquine given concurrently with each of the 
first two doses of chloroquine followed by a 0.5 mg/kg dose with the last dose of chloroquine 
on day 2. 
- Data adapted from Baird et all8. 
Halofantrine has been investigated in 
Arso, both alone and in conjunction with 
standard primaquine t h e r a ~ y . ' ~ " ~  Table 3 shows 
the results; either regimen was highly effective 
against these predominantly chloroquine- 
resistant infections, but primaquine offered the 
advantage of killing liver schizonts and 
sterilizing any sunriving gamctocytes. 
Halofantrine is a relatively expensive anti- 
malarial currently protected by patent rights. It 
may be more than 10 years bcfore its general 
use in Irian hya  is economically practical 
In view of this, trials of combinations of 
antimalarials not protected by patent rights 
should be considered. For example, a trial of 
chloroquine in combination with doxycycline 
begins soon in Irian Jaya. If effective, this 
regimen could provide safe, effective and 
affordable therapy (although pregnant women 
and children would yet need some other 
solution). Extensive trials of standard 
chloroquine therapy followed by a single 
curative dose of Fansldar have shown great 
pronlrse ~ s l  the Philippines (Q. Rmstos, M W ,  
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Manila; personal communication). This 
practical approach to developing 'new' therapies 
for malaria is now being applied around the 
world. Many investigators recognize that costly 
antimalarials offer little or no immediate relief 
for the vast majority of people who must live 
with endemic malaria. Nonetheless, the 
development of new antimalarials, even though 
not immediately affordable, represents an 
essential step forward and a necessary 
investment for the future. 
Vector Control. 
Where epidemic malaria occurs, 
mosquitoes tell the story of causality. In 
northeastern Irian Jaya the punctulatus group of 
anophelines dominate as vectors of malaria. 
Multiple characteristics of these vectors 
combine to create extreme difficulties for vector 
control activities in areas like Arso. 
First, there are few cattle, goats, dogs or 
cats in new transmigration communities; the 
mosquitoes, which will feed on both animals 
and man, focus upon the humans as targets. 
Second, the mosquitoes feed both indoors 
and outdoors with fairly even frequency 
throughout the This outdoor feeding 
coinpromses the value of mosquito nets. Even 
when feeding indoors, they tend not to rest on 
interior walls. This restricts the number of 
mosquitoes that can be exposed to insecticides 
Table 3. Summary of trials of halofantrine for therapy of vivax and falciparum malaria in 
the Arso region of Irian Jaya, 1993-1994. 
* Standard regimen of halofantrine of three doses of 8 mgkg given at 6 hr intervals. Data adapted 
from Baird et al. ". 
A Standard regimen of halofantrine as above, plus 0.5 mgkg primaquine base daily for 14 days 
beginning the day after halofantrine. Data adapted from FryaufF and others (manuscript in 
preparation). 
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applied upon interior walls or upon mosquito 
netting. It may explain the results of a recent 
trial comparing treated to untreated bednets in 
Arso PIR IV: no difference in the incidence of 
malaria was detected between the two study 
groups (C. Church, unpublished). 
Third, the environmental conditions in 
new transmigration villages create many 
breeding sites for the anophelines, which prefer 
breeding in bright, temporary pools. Areas of 
newly cleared rain forest are brightly sunlit, 
easily softened by rain, and the shallow, 
nutrient-rich pools created in mud by human, 
animal and machine traffic become increasingly 
exploited for anopheline breeding. These 
countless breeding sites in rain-filled footprints 
and tire ruts, usually in close proximity to 
homes, are often too shallow and impermanent 
to permit the establishment of natural predators 
like dragonfly larvae, tadpoles, and fish. 
What can be done to attack these vectors? 
Education and community-based action may be 
the most effective weapons. Residents of 
transmigration villages manage virtually every 
square meter of their settlements with great 
care. Alerting residents to the danger 
represented by temporary sunlit pools may allow 
them to destroy many pools with a few turns of 
the hoe. Minimizing exposure to biting 
mosquitoes by wearing long pants and long 
sleeve shirts during the evening can be 
encouraged. Use of mosquito nets generally 
does not require prompting or encouragement 
(nets offer relief from sleep disturbed by both 
biting and crawling insects); the diff~culty here 
tend9 to be economic, ie., supplying and 
maintairdng the integrity of the netting. 
Keeping animals likP goats and cattle near the 
home at night may diminish the intensity of 
mosquitoes in the house seeking blood meals 
(mprophylaxis). Iawticide impregnated 
curtains for windows and shams for eaves may 
also diminish the risk of infection within the 
house. Special protection for people who 
remain outdoors all night, like soldiers and 
siskamling jagas, may prevent the relatively 
high attack rates known to occur in these people 
(C. Ohrt 62 D.J. Fryauff, personal 
communication). Chemical lotions that repel 
mosquitoes, mosquito coils, and mandatory 
protective clothing may suffice. Outdoor social 
functions held in the evening may contribute 
appreciable community risk, but with judicious 
use of topical repellents and protective clothing, 
this risk could be minimized. 
SUMMARY AND RECOMMENDATIONS 
Epidemic malaria is a significant problem 
for new transmigration communities in heavily 
endemic areas. Measured attack rates in the 
Arso region of Irian Jaya illustrate the severity 
of this challenge. Current strategies intended to 
control malaria in these communities are faced 
with the following challenges: 1) high rates 
and degrees of resistance to chloroquine and the 
lack of alternatives for prophylaxis or therapy, 
2) limited on-site diagnostic capability, 3) the 
inherent difficulty of vector control due to 
unique feeding and breeding behaviors, and 4) 
the absence of a strategy which targets 
asymptomatic infectious carriers of disease. 
New transmigrants brought to highly 
malarious areas merit special attention and 
dedication of resources. This special targeting 
allows attention and expenditures that may 
prevent epidemic malaria and greatly improve 
the social and economic vitality of 
transmigration areas. Establishing a cycle of 
health -and economic growth (in contrast to 
disease an! poverty) may ultimately overwhelm 
endemic malaria. 
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TEN MEASURES TO REDUCE THE RISK 
OF EPIDEMIC MALARIA AMONG 
TRANSMIGRANTS: 
1. Screen all candidate transmigrants for 
G-6-PD deficiency (approximately 
Rp.1000 per test) and provide supervised 
prophylaxis for three months as current 
policy dictates. Consider primaquine 
prophylaxis for non-pregnant, G-6-PD 
normal individuals. 
2. Increased financial and administrative 
support for public health officers charged 
with the responsibility and granted the 
authority to command resources needed to 
avert epidemic malaria, specifically among 
newcomers. This should include the 
training and equipment necessary to 
accomplish clearly identified plans and 
realistic goals. These should be formulated 
in view of local conditions and vector 
bionomics. 
3. Establish on-site microscopic diagnostic 
capability, to include monthly active case 
detection among all residents and 
eliminate asymptomatic ganletocytemias 
for a period of six months. 
prevent transmission (to be repeated along 
with institution of alternative therapy for 
those infections that recrudesce during 
follow-up). 
6. Provide mosquito nets, curtains anu shams 
(evidence suggests that in the case of 
bednets used in Arso, impregnation with 
insecticide provides no added benefit and 
may increase expoaire to potentially toxic 
chemicals?. 
7. Conduct education programs on-site to 
inform people about mosquito vector 
bionomics (identify breeding sites and 
feeding behaviors), along with 
emphasizing the ianportance of prompt 
diagnosis and efSective therapy of 
infection. 
8, Organize a cadre of local volunteers 
trained to: a) recognize symptoms of 
malaria in their neighbors and encourage 
them to seek treatment; b) spot and 
eliminate mosquito breeding sites; c) 
understand mosquito feeding activities and 
personal protective measures and to 
encorirage this in their neighbors; d) 
collect blood films to provide essential 
4. Before the newcomers arrive, screen and assistance to the local slide reader, and e) 
treat construction teams and indigenous re-impregnate netting, curtains and shams 
people who will live with them, and as appropriate, f) work with local public 
provide G-6-PD testing and prophylaxis to health authorities in planning and 
them as well. implementing strategies against malaria. 
5. Provide effective therapeutics for 
slide-proven malaria, eg., chloroquine (or 
chloroquine-primaquine for P. vivax, or 
another chloroquine combination) with 
careful microscopic follow-up and 
institution of alternative treatment in 
resistant cases. Include a standard two 
week curative regimen of primaquine with 
each infection regardless of species, or 3t 
leas! provide a single primaquine dose to 
9. Provide reliable motorized transport to 
evacuate severely sick or injured patients 
to hospital. 
10. OfTer an incentive to spur community 
participation in malaria control efforts, 
eg., a generator, television and parabola 
given to villages with a prevalence of 
mdaria < 10% after six months. 
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